Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$2.05 USD
+0.07 (3.54%)
Updated Aug 12, 2024 03:59 PM ET
After-Market: $2.06 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.03 | -5.00% |
Earnings Summary
For their last quarter, Heron Therapeutics (HRTX) reported earnings of -$0.06 per share, missing the Zacks Consensus Estimate of -$0.04 per share. This reflects a negative earnings surprise of 50.00%. Look out for HRTX's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.03 per share, reflecting a year-over-year increase of 82.35%.
Earnings History
Price & Consensus
Zacks News for HRTX
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
HRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services